Company profile
Rivia SA
Rivia is a cloud-based platform for Biotechs to analyse drug clinical trials from one location. Our Software-as-a-Service provides a back-end platform that integrates clinical trial data, combined with a front-end interface to analyse patients and trial metrics. Rivia allows Biotechs to focus on generating trial insights by eliminating manual data tasks.
Source: startup.ch
Highlights
Winner Venture Kick
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
